Inhibition of p38 MAP kinase activity enhances axonal regeneration

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 606-614

  Myers, Robert R ^a,d   Sekiguchi, Yasufumi ^b   Kikuchi, Shinichi ^b   Scott, Brian ^c   Medicherla, Satya ^c   Protter, Andrew ^c   Campana, W Marie ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c SCIOS INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Axonal regeneration; Degeneration; p38 MAPK; Schwann cell; TNF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; SD 169; SILICONE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; CRUSH TRAUMA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; EXPERIMENTAL TEST; FEEDING; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOLECULAR INTERACTION; MORPHOLOGY; NERVE CELL CULTURE; NERVE CRUSH; NERVE FIBER REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TISSUE SECTION; WESTERN BLOTTING;

EID: 0842320919     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00297-8     Document Type: Article

References (33)

1. Badger A.M., Bradbeetr J.N., Votta B., Lee J.C., Adams J.L., Griswold D.E. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1996;1453-1461.
2. Berti-Mattera L.N., Harwalkar S., Hughes B., Wilkins P.L., Almhanna K. Proliferative and morphological effects of endothelins in Schwann cells: roles of p38 mitogen-activated protein kinase and Ca(2+)-independent phospholipase A2. J. Neurochem. 79:2001;1136-1148.
3. Bonetti B., Valdo P., Stegagno C., Tanel R., Zanusso G.L., Ramarli D., Fiorini E., Turazzi S., Carner M., Moretto G. Tumor necrosis factor alpha and human Schwann cells: signaling and phenotype modulation without cell death. J. Neuropathol. Exp. Neurol. 59:2000;74-84.
4. Calcutt N.A., McMurray H.F., Moorhouse D.F., Bache M., Parthasarathy S., Powell H.C., Mizisin A.P. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor Tolrestat. Exp. Neurol. 128:1994;226-232.
5. Campana W.M., Myers R.R. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J. 15:2001;1804-1806.
6. Campana W.M., Hiraiwa M., Addison K.C., O'Brien J.S. Induction of MAPK phosphorylation by prosaposin and prosaptide in PC12 cells. Biochem. Biophys. Res. Comm. 229:1996;706-712.
7. Campana W.M., Hiraiwa M., O'Brien J.S. Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J. 3:1998;307-314.
8. Campana W.M., Darin S.J., O'Brien J.S. Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells. J. Neurosci. Res. 57:1999;332-341.
9. Faour W.H., He Y., He Q.W., de Ladurantaye M., Quintero M., Mancini A., Di Battista J.A. Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J. Biol. Chem. 276:2001;31720-31731.
10. Gingras A.C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:1999;913-963.
11. Gutmann E., Gutmann L., Medawar P.B., Young J.Z. The rate of regeneration of nerve. J. Exp. Biol. 19:1942;14-44.
12. Herdegen T., Waetzig V. The JNK and p38 signal transduction following axotomy. Restor. Neurol. Neurosci. 19:2001;29-39.
13. Hiraiwa M., Taylor E.M., Campana W.M., Darin S.J., O'Brien J.S. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4778-4781.
14. Ide C. Peripheral nerve regeneration. Neurosci. Res. 25:1996;101-121.
15. Jeohn G.-H., Cooper C.L., Jang K.-J., Liu B., Lee D.-S., Kim H.-C., Hong J.-S. Gö6976 inhibits LPS-induced microglial TNFα release by suppressing p38 MAP kinase activation. Neuroscience. 114:2002;689-697.
16. Ji R.-R., Samad T.A., Jin S.-X., Schmoll R., Woolf C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 36:2002;57-68.
17. Ju H., Nerurkar S., Sauermelch C.F., Olzinski A.R., Mirabile R., Zimmerman D., Lee J.C., Adams J., Sisko J., Berova M., Willette R.N. Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury. J. Pharmacol. Exp. Ther. 301:2002;15-20.
18. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal J.J., Heys J.R., Landvatter S.W.et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
19. Lee Y.B., Schrader J.W., Kim S.U. p38 MAP kinase regulates TNF-α production in human astrocytes and microglia by multiple mechanisms. Cytokine. 12:2000;874-880.
20. Liefner M., Siebert H., Sachse T., Michel U., Kollias G., Bruck W. The role of TNF-alpha during Wallerian degeneration. J. Neuroimmunol. 108:2000;147-152.
21. Martin-Blanco E. p38 MAPK signalling cascades: ancient roles and new functions. BioEssays. 22:2000;637-645.
22. Myers R.R. Morphology of the peripheral nervous system and its relationship to neuropathic pain. Yaksh T.L. Anesthesia: Biologic Foundations. 1997;483-513 Lippincott-Raven Publishers, Philadelphia.
23. Myers R.R., Wagner R., Sorkin L.S. Hyperalgesia actions of cytokines on the peripheral nervous system. Watkins L. Cytokines and Pain: Progress in Inflammation Research. 1999;133-158 Birkhauser Verlag, Basal.
24. Nakahara S., Yone K., Sakou T., Wada S., Nagamine T., Niyama T., Ichijo H. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. J. Neuropathol. Exp. Neurol. 58:1999;442-450.
25. Peng T., Lu X., Lei M., Feng Q. Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-alpha expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. J. Biol. Chem. 278:2003;8099-8105.
26. Podhajsky R.J., Myers R.R. The vascular response to nerve transection: neovascularization in the silicone nerve regeneration chamber. Brain Res. 662:1994;88-94.
27. Stoll G., Jander S., Myers R.R. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J. Peripher. Nerv. Syst. 7:2003;13-27.
28. Wagner R., Myers R.R. Schwann cells produce TNF-alpha: expression in injured and non-injured nerves. Neuroscience. 73:1996;625-629.
29. Wagner R., Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. NeuroReport. 7:1996;2897-2901.
30. Weidner N., Blesch A., Grill R.J., Tuszynski M.H. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J. Comp. Neurol. 413:1999;495-506.
31. Weishaupt A., Bruck W., Hartung T., Toyka K.V., Gold R. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha. Neurosci. Lett. 306:2001;77-80.
32. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
33. Xing J., Komhauser J.M., Xia Z., Thiele E.A., Greenberg M.E. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18:1998;1946-1955.